Clincosm LogoSign in Get a demo

Acute Myelogenous Leukemia

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

Terminated
  • High-risk Myelodysplastic Syndromes
  • +3 more
  • GTB-3550 TriKE® Phase I
  • GTB-3550 TriKE® Phase II
  • Minneapolis, Minnesota
  • +1 more
Mar 21, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
Has Results
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +4 more
  • Single Umbilical Cord Blood Unit Transplant
  • +6 more
  • Birmingham, Alabama
  • +37 more
Oct 13, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Acute Myelogenous Leukemia Trial in United States (KIR genotype)

Completed
  • Acute Myelogenous Leukemia
  • KIR genotype
  • Scottsdale, Arizona
  • +18 more
Mar 9, 2021

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Acute Myelogenous Leukemia Trial in Chicago, Minneapolis, Columbus (Interventions)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Interventions
  • Chicago, Illinois
  • +2 more
Jul 8, 2020

Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive

Completed
Has Results
  • Acute Myeloid Leukemia
  • Acute Myelogenous Leukemia
  • Tucson, Arizona
  • +29 more
Jun 17, 2019

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (iTreg)

Completed
  • Acute Myelogenous Leukemia
  • +7 more
  • iTreg
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 17, 2019

Acute Myelogenous Leukemia Trial in Minneapolis (IL-15)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • IL-15
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 22, 2018

Acute Myelogenous Leukemia, Refractory Acute Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Refractory Acute Myelogenous Leukemia
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myelogenous Leukemia Trial in Minneapolis (biological, drug, procedure, radiation)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • aldesleukin
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Minneapolis (90Y-AHN-12)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • 90Y-AHN-12
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myelogenous Leukemia Trial in Minneapolis, Saint Louis (biological, device, drug)

Withdrawn
  • Acute Myelogenous Leukemia
  • CD3-/CD19- natural killer cells
  • +6 more
  • Minneapolis, Minnesota
  • +1 more
Nov 29, 2017

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Minneapolis (Preparative Regimen, Intravenous Recombinant Human

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Preparative Regimen
  • Intravenous Recombinant Human IL-15 (rhIL-15)
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 29, 2017